Konfident302 vs PHA022121
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Konfident302
Read full descriptionHide full description
The Konfident302 clinical trial app is designed to enable participants to complete study assessments easily and from their own mobile device. Access is restricted to registered participants in possession of a valid activation code. The app does not provide medical advice. Please consult with your study doctor with any questions or concerns you may have regarding your individual needs or medical conditions or any related questions about your participation in the study.
PHA022121
Read full descriptionHide full description
The PHA022121-C303 app is intended to collect patient reported outcomes for the PHA022121-C303 clinical study. Your study site will provide you with a QR code to activate your app at your first visit.
Screenshots
Verdict
The clearest difference is update cadence: Konfident302 at every 2 weeks against PHA022121's monthly. On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Konfident302 ships an update every 2 weeks, PHA022121 monthly. The most recent releases landed on October 2, 2026 and October 9, 2026 respectively.
| Parameter | Konfident302 | PHA022121 |
|---|---|---|
| Price | Free | Free |
| Update frequency | Every 2 weeks — better | Monthly |
| Ads | No | No |
| In-app purchases | No | No |
| Devices | iPhone, iPod | iPhone, iPad, iPod — better |
| Requires iOS | 12.4 | 12.0 — better |
| Further details — not scored | ||
| Size | 23 MB | 81 MB |
| Age rating | 12+ | 12+ |
| Developer | Snapiot Inc | ERT,INC |
In-app purchases
Konfident302
No in-app purchases
PHA022121
No in-app purchases
